Human-centric compound research focuses on:
Radiolabelled compounds (e.g., ¹⁴C-labeled molecules) for tracking absorption, metabolism, and excretion (AME) .
Immunomodulatory compounds like AH10-7, which selectively activate tumor-fighting invariant natural killer T (iNKT) cells .
Small-molecule therapeutics analyzed via AI models (e.g., CODE-AE) for efficacy prediction .
Absorption, Metabolism, Excretion (AME) studies use radiolabelled compounds to evaluate drug behavior:
Outputs: Metabolite proportions, biotransformation pathways, and high-resolution MS/MS spectra .
Guidelines: FDA MIST, ICH M3(R2), and EMA DDI dictate metabolite safety thresholds (>10% AUC of total drug-related material) .
Technologies: Accelerator Mass Spectrometry (AMS) enables ultra-sensitive detection of ¹⁴C compounds in biological matrices .
Mechanism: Hydrocinnamoyl ester modification enhances stability and Th1 cytokine bias, improving antitumor response .
Efficacy: Suppressed melanoma growth in humanized mice at levels comparable to benchmark ligand KRN7000 .
Function: Predicts human responses to novel compounds using genomic and structural data .
Performance: Identified personalized drugs for >9,000 patients in theoretical tests .
Cytotoxicity Prediction: Current models show modest accuracy (Pearson’s r < 0.28 for individual responses) but improve for population-level predictions (r < 0.66) .
Metabolite Safety: Human-specific metabolites not observed in animal models require early AME studies to mitigate toxicity risks .
COMP, a large glycoprotein, plays a crucial role in cartilage health. As a member of the thrombospondin family, this non-collagenous protein is found abundantly in the extracellular matrix of various cartilaginous tissues like articular, nasal, and tracheal cartilage. Its presence extends to other tissues such as synovium and tendon. COMP forms a pentameric structure, with each subunit contributing to its high molecular weight exceeding 500kDa. This protein exhibits calcium-binding properties. The carboxy-terminal globular domain of COMP interacts with collagen types I, II, and IX, highlighting its importance in maintaining the structural integrity and characteristics of the collagen network. Additionally, COMP serves as a reservoir and transporter for signaling molecules like vitamin D. Genetic mutations affecting COMP are linked to skeletal disorders like Pseudoachondroplasia and certain types of multiple epiphyseal dysplasia, emphasizing its crucial role in skeletal development and function.
Recombinant human COMP, produced in HEK293 cells, is a single polypeptide chain that has been glycosylated. This protein consists of 749 amino acids (specifically, residues 21 to 757), resulting in a molecular weight of 82.4kDa. To facilitate purification, a 6-amino acid His tag is attached to the C-terminus. The purification process utilizes proprietary chromatographic methods to ensure high purity.
The appearance of the solution is a clear and colorless liquid that has been sterilized by filtration.
The COMP solution is provided at a concentration of 0.5mg/ml and is prepared in a phosphate buffered saline solution (pH 7.4) containing 10% glycerol.
For short-term storage (up to 2-4 weeks), the COMP solution should be stored at a refrigerated temperature of 4°C. For extended storage, it is recommended to store the solution in a frozen state at -20°C. To further enhance stability during long-term storage, the addition of a carrier protein like HSA or BSA (at a concentration of 0.1%) is advisable. To maintain the quality of the protein, it is crucial to minimize the number of freeze-thaw cycles.
The purity of this product is determined using SDS-PAGE analysis and is guaranteed to be greater than 85.0%.
Cartilage Oligomeric Matrix Protein (pseudoachondroplasia epiphyseal dysplasia 1 multiple), MED, THBS5, TSP5, EDM1, PSACH, EPD1, Thrombospondin-5
HEK293 Cells.
ADPDAHSLWY NFTIIHLPRH GQQWCEVQSQ VDQKNFLSYD CGSDKVLSMG HLEEQLYATD AWGKQLEMLR EVGQRLRLEL ADTELEDFTP SGPLTLQVRM SCECEADGYI RGSWQFSFDG RKFLLFDSNN RKWTVVHAGA RRMKEKWEKD SGLTTFFKMV SMRDCKSWLR DFLMHRKKRL EPTAPPTMAP GLEPKSCDKT HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SRDELTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGKHHHHHH
Computational human research follows a structured experimental design flow to ensure scientific rigor. The process typically involves:
Formulating a clear research question
Developing testable hypotheses
Identifying independent, dependent, and control variables
Determining appropriate experimental design structure
Calculating required sample size for statistical power
Implementing random assignment and selection
Executing the experiment with data collection
Analyzing collected data with appropriate statistical methods
Interpreting findings and drawing inferences
Documenting and reporting results comprehensively
This methodical approach ensures that human subject research maintains integrity through principles of replication, randomization, control, and blocking . Replication verifies reliability, randomization prevents bias, control groups provide comparative baselines, and blocking accounts for participant characteristics that might influence outcomes .
When designing HCI studies, researchers must carefully classify variables to ensure methodological clarity:
| Variable Type | Definition | Examples in HCI Research |
|---|---|---|
| Independent | Variables manipulated by researchers | Interface design, information presentation methods, interaction modalities |
| Dependent | Outcome measurements | Task completion time, error rates, user satisfaction scores |
| Control | Variables held constant | Environment conditions, task instructions, hardware specifications |
| Confounding | Variables that may influence results if not controlled | Prior experience, age, cognitive abilities |
| Blocking | Variables used to group participants | Expertise level, demographic factors, cognitive traits |
Proper variable classification is essential for valid hypothesis testing. For complex HCI studies, researchers should consider mixed-method approaches that balance quantitative measurements with qualitative insights to capture the multidimensional nature of human-computer interaction . This approach helps address the challenge that human responses often involve both measurable performance metrics and subjective experience factors.
Valid human subject data collection requires adherence to several fundamental principles:
Systematic Investigation: Research must follow structured protocols that incorporate both data collection and analysis methods designed to answer specific questions .
Appropriate Sampling: Sample selection should represent the target population while accounting for practical constraints. Sample size calculations should be performed to ensure adequate statistical power .
Standardized Procedures: All participants should experience consistent experimental conditions with standardized instructions and procedures to minimize unintended variability .
Ethical Considerations: Research must prioritize participant welfare through informed consent, risk minimization, and privacy protection as defined by institutional review boards and relevant regulations .
Measurement Validity: Data collection instruments must accurately measure what they purport to measure, whether they are surveys, behavioral observations, or physiological recordings .
Rigorous Documentation: Detailed records of all procedures, unexpected events, and methodological decisions enable transparency and replicability .
The HHS defines human subject research as involving living individuals from whom researchers obtain data through intervention/interaction or identifiable private information . This definition guides methodological decisions throughout the research process.
Effective mixed-method approaches in HCI research require strategic integration:
Sequential Design: Begin with one method and use findings to inform the other. For example, conduct qualitative interviews to develop hypotheses, then test them quantitatively via controlled experiments .
Concurrent Design: Collect both types of data simultaneously, allowing triangulation of findings. This approach provides complementary perspectives on the same research questions .
Data Transformation: Convert qualitative data to quantitative (quantitization) or interpret quantitative results through qualitative lenses (qualitization) to enhance analytical depth .
Integration Points:
Design phase: Use mixed methods to develop more robust research questions
Collection phase: Gather complementary data types simultaneously
Analysis phase: Cross-validate findings between methods
Interpretation phase: Develop more comprehensive explanations
Contradictions in dialogue modeling and human-machine interaction data present significant analytical challenges requiring sophisticated approaches:
Structured vs. Unstructured Analysis: Research indicates that structured approaches—where utterances are paired separately before processing—often outperform unstructured approaches where concatenated dialogues are analyzed as a whole. This structured method explicitly accounts for natural dialogue patterns and relation-specific contradictions .
Contradiction Types Taxonomy: Develop a classification system for contradiction types that distinguishes between:
Self-contradictions (within single agent utterances)
Cross-turn contradictions (between turns in a conversation)
Contextual contradictions (between utterance and contextual knowledge)
Temporal contradictions (statements contradicting earlier factual assertions)
Out-of-Distribution Testing: Include human-labeled contradictions from diverse dialogue settings, particularly human-bot interactions, to evaluate model robustness beyond training distributions .
Natural Language Inference (NLI) Models: Advanced research employs specialized NLI models trained to detect contradictions within dialogue structures rather than relying on general language models. These approaches typically require specialized training data containing both human-human and human-bot contradictory dialogues .
For researchers dealing with human-machine dialogue data, validation across multiple dialogue contexts is essential, as contradiction patterns differ significantly between human-human conversations and human-machine interactions .
Computational prediction of human responses to toxic compounds represents a frontier in predictive toxicology, with several methodological approaches:
Population-Based Genomic Prediction: Studies have demonstrated that while individual-level cytotoxicity predictions remain challenging (Pearson's r < 0.28), population-level response predictions can achieve higher correlations (r < 0.66). This difference highlights the complexity of individual-specific genetic factors versus general toxicity mechanisms .
Integrated Predictive Approaches:
| Approach | Data Sources | Strengths | Limitations |
|---|---|---|---|
| Structure-Based | Compound structural attributes | Requires no biological testing | May miss biological mechanisms |
| Genomic Profile-Based | Individual genotype & transcriptomic data | Person-specific predictions | Modest individual prediction accuracy |
| Hybrid Models | Combined structural and genomic data | Improved predictive power | Computational complexity |
| Population-Average Models | Aggregated cytotoxicity data | Better generalizability | Lacks individual specificity |
Validation Methodologies: To establish reliability, predictions must be evaluated against blinded experimental datasets with diverse compounds and genetic profiles. The Tox21 1000 Genomes Project provides valuable validation resources, measuring cytotoxicity of compounds across hundreds of cell lines with known genetic profiles .
This research area demonstrates the potential for predicting population health risks from unknown compounds, though individual-level prediction accuracy remains suboptimal due to the complex genetic determinants of toxic response variation .
Detecting individual differences in HCI requires specialized experimental designs that balance internal validity with sensitivity to variation:
Within-Subject Factorial Designs: These designs offer superior power for detecting individual differences by controlling for person-specific variance. Each participant experiences multiple experimental conditions, allowing researchers to isolate interaction effects between individual traits and interface variables .
Adaptive Testing Protocols: Dynamic adjustment of task difficulty or interface parameters based on individual performance characteristics can reveal differences that fixed designs might obscure .
Individual Differences Blocking: Stratifying participants based on theoretically relevant characteristics (cognitive abilities, expertise, personality traits) before random assignment improves detection of attribute-specific interaction patterns .
Mixed-Effects Modeling Approaches: Statistical techniques that incorporate both fixed effects (experimental manipulations) and random effects (individual variation) provide powerful tools for quantifying individual difference components .
The Computer-Aided Design Reference for Experiments (CADRE) tool offers researchers specialized guidance for human factors experimental design that accommodates individual difference analysis . Modern approaches emphasize that capturing individual differences requires larger sample sizes than traditional experiments, with power analyses specifically accounting for expected interaction effect sizes .
Human AME studies provide critical data for computational modeling of drug pharmacokinetics and require specialized methodological approaches:
Integrated Radiolabeled Sciences Approach: Comprehensive human AME studies utilize 14C radiolabeled compounds to track absorption, metabolism, and excretion processes with high precision. The methodological workflow integrates:
Micro vs. Macro Tracer Methodologies:
| Protocol Type | Radioactive Dose | Analysis Method | Applications |
|---|---|---|---|
| Low 14C (Micro Tracer) | ~1-5 μCi with therapeutic dose | AMS | Reduced radiation exposure, suitable for most AME studies |
| High 14C (Macro Tracer) | ~100-200 μCi with therapeutic dose | Liquid Scintillation Counting (LSC) | Higher sensitivity for certain metabolites |
| Hybrid Design | Variable | LSC for early timepoints, AMS for later | Optimized sensitivity across timepoints |
Computational Integration: Modern approaches use these experimental data to develop physiologically-based pharmacokinetic (PBPK) models that predict compound behavior in diverse human populations. Effective implementation requires:
Phase 0 microdose studies under exploratory investigational new drug (eIND) applications provide early-stage evaluation of pharmacokinetics and excretion patterns, generating valuable data for initial computational model development with minimal human exposure .
Google's People Also Ask (PAA) feature represents an underutilized resource for identifying research priorities and knowledge gaps in computational human research:
Systematic Question Extraction: Researchers should implement a structured approach to extracting PAA data:
Intent Analysis Framework: PAA data reveals underlying search intent patterns that can inform research priorities:
Temporal Monitoring: PAA questions change over time, reflecting evolving research interests and knowledge gaps. Regular monitoring provides insights into emerging research directions and changing priorities within the field .
Content Strategy Alignment: Research programs can gain relevance by addressing the questions most frequently asked by the scientific community and stakeholders, as reflected in PAA data .
PAA features appear in over 80% of English searches, generally within the first few results, making them a widespread indicator of information needs. For computational human research specifically, tracking these questions helps identify where methodological uncertainty or controversy exists in the field .
Designing experiments for human-machine dialogue requires specialized methodological considerations:
Contradiction-Aware Experimental Design:
Dialogue Data Collection Protocol:
| Phase | Key Considerations | Implementation Notes |
|---|---|---|
| Preparation | Define contradiction taxonomies | Classify by type, severity, and intentionality |
| Participant Selection | Diverse demographic sampling | Include both expert and naive users |
| Task Design | Balance directive vs. exploratory tasks | Provide scenarios that naturally elicit complex dialogues |
| Recording | Capture full context including non-verbal cues | Ensure time-synchronized multimodal data |
| Annotation | Multi-rater contradiction labeling | Calculate inter-rater reliability metrics |
Research indicates that contradictions in human-bot dialogues differ qualitatively from those in human-human interactions, necessitating specialized evaluation frameworks and testing environments .
Integration of computational prediction models with human subject data requires methodological rigor to maintain validity:
Bidirectional Integration Framework:
| Integration Direction | Methodology | Applications |
|---|---|---|
| Model → Experiment | Use model predictions to inform experimental design | Prioritize conditions, optimize sampling, focus hypotheses |
| Experiment → Model | Refine models based on experimental findings | Parameter adjustment, architecture refinement, feature selection |
| Iterative Cycle | Alternate between modeling and experimentation | Progressive refinement, targeted exploration of discrepancies |
Cross-Validation Strategies:
Integration Challenges and Solutions:
Scale mismatch: Develop normalization approaches for model and human data
Temporal alignment: Implement time-warping algorithms for dynamic processes
Individual variability: Incorporate individual-specific parameters in models
Uncertainty representation: Propagate uncertainty from both sources through integration
Research on human population responses to toxic compounds demonstrates this integration approach, where computational predictions of cytotoxicity were systematically compared with experimental measurements across 884 lymphoblastoid cell lines, revealing stronger performance for population-level predictions (r < 0.66) than individual-level predictions (r < 0.28) .
Computational research with human subjects must adhere to specific ethical requirements:
Regulatory Framework: Human subject research is governed by institutional review boards (IRBs) operating under regulatory frameworks such as HHS regulations (45 CFR 46.102), which define human subjects as living individuals about whom researchers obtain data through intervention/interaction or identifiable private information .
Core Ethical Requirements:
| Requirement | Implementation in Computational Research | Regulatory Basis |
|---|---|---|
| Informed Consent | Clear disclosure of data collection, processing, and potential risks | Respect for persons principle |
| Risk Minimization | Data security protocols, privacy protections, psychological safeguards | Beneficence principle |
| Justice in Subject Selection | Representative sampling, inclusion of diverse populations | Justice principle |
| Scientific Validity | Methodological rigor, appropriate sample sizes, valid analysis methods | Research ethics codes |
| Privacy and Confidentiality | Data anonymization, secure storage, restricted access protocols | Data protection regulations |
Special Considerations for Computational Methods:
Algorithm transparency: Participants should understand how their data will be processed
Secondary data use: Restrictions on repurposing collected data for other analyses
Data retention: Clear policies on storage duration and eventual destruction
Re-identification risks: Assessment of potential for anonymous data to become identifying through combination with other datasets
Computational research involving vulnerable populations (children, cognitively impaired individuals, etc.) requires additional protections and specialized consent procedures as outlined in research ethics guidelines .
Ensuring diverse representation in HCI research requires intentional methodological approaches:
Sampling Strategy Framework:
Inclusive Research Design Considerations:
Analysis Approaches for Diversity:
Recent advancements in HCI research methodologies emphasize the importance of conducting research with diverse populations including children, older adults, and individuals with cognitive impairments, requiring specialized approaches tailored to these groups' needs and capabilities .
Data privacy in computational human research requires robust methodological protections:
Privacy-Preserving Research Design:
Technical Protection Measures:
| Technique | Implementation | Privacy Benefit |
|---|---|---|
| Differential Privacy | Add calibrated noise to data or results | Prevents individual identification while preserving aggregate insights |
| Federated Learning | Process data locally without central collection | Raw data remains under subject control |
| Secure Multi-Party Computation | Collaborative computation without sharing raw data | Enables analysis across institutions without data transfer |
| Homomorphic Encryption | Compute on encrypted data | Allows processing without exposure of raw information |
Consent and Control Mechanisms:
Documentation and Accountability:
These practices align with regulatory requirements while addressing the unique challenges of computational methods that may identify patterns in seemingly anonymous data that could lead to re-identification of research participants .
COMP is a large, pentameric glycoprotein with a molecular weight of approximately 550 kDa. It belongs to the thrombospondin gene family and is characterized by its disulfide-linked structure. The protein contains several domains, including epidermal growth factor-like repeats and calcium-binding repeats, which are essential for its function .
COMP is primarily involved in the assembly and stabilization of the extracellular matrix in cartilage. It binds to various matrix components, including collagen types I, II, and IX, and matrilins . This binding capability is crucial for maintaining the structural integrity of cartilage and facilitating chondrogenesis, the process by which cartilage is formed .
COMP is present during the early stages of human limb development and continues to play a role in maintaining healthy cartilage throughout life . However, its expression is significantly upregulated in conditions such as osteoarthritis (OA) and rheumatoid arthritis (RA) . In OA, COMP is secreted by chondrocytes and is often associated with collagen fibers in the cartilage matrix . Elevated levels of COMP have been detected in the serum and synovial fluid of patients with OA, making it a potential biomarker for the disease .
The human recombinant form of COMP is produced using recombinant DNA technology, which involves inserting the COMP gene into a host cell to produce the protein. This recombinant protein is used in various research applications to study its structure, function, and role in diseases. It is also utilized in developing therapeutic strategies for cartilage-related disorders .
Due to its involvement in cartilage integrity and disease, COMP has garnered significant interest as a potential therapeutic target. Research has shown that COMP can induce arthritis in animal models, providing insights into the pathogenesis of RA . Additionally, its role as a biomarker for musculoskeletal diseases like knee OA highlights its diagnostic potential .